525 related articles for article (PubMed ID: 18759920)
21. [Influence factors of reconstitution of killer cell immunoglobulin-like receptor on NK cells following non-T-cell-depleted haploidentical hematopoietic stem cell transplantation].
Zhao XY; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):103-6. PubMed ID: 17650670
[TBL] [Abstract][Full Text] [Related]
22. The immunobiology of natural killer cells and bone marrow allograft rejection.
Barao I; Murphy WJ
Biol Blood Marrow Transplant; 2003 Dec; 9(12):727-41. PubMed ID: 14677112
[TBL] [Abstract][Full Text] [Related]
23. NK cell receptors and their ligands in leukemia.
Verheyden S; Demanet C
Leukemia; 2008 Feb; 22(2):249-57. PubMed ID: 18046448
[TBL] [Abstract][Full Text] [Related]
24. KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation.
Malmberg KJ; Schaffer M; Ringdén O; Remberger M; Ljunggren HG
Mol Immunol; 2005 Feb; 42(4):531-4. PubMed ID: 15607809
[TBL] [Abstract][Full Text] [Related]
25. Immunology. A perfect mismatch.
Kärre K
Science; 2002 Mar; 295(5562):2029-31. PubMed ID: 11896262
[No Abstract] [Full Text] [Related]
26. KIR matching in hematopoietic stem cell transplantation.
Bignon JD; Gagne K
Curr Opin Immunol; 2005 Oct; 17(5):553-9. PubMed ID: 16085405
[TBL] [Abstract][Full Text] [Related]
27. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
28. [Role of NK cell receptor-expressing cells in the regulation of GVHD and GVL].
Tanaka J
Rinsho Ketsueki; 2008 Aug; 49(8):598-606. PubMed ID: 18800608
[No Abstract] [Full Text] [Related]
29. The activating killer cell immunoglobulin-like receptors as important determinants of acute graft-versus host disease in hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ; Choi Y; Min WS; Kim TG; Cho BS; Kim SY; Eom KS; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Kim CC
Transplantation; 2007 Nov; 84(9):1082-91. PubMed ID: 17998861
[TBL] [Abstract][Full Text] [Related]
30. Influence of killer cell immunoglobulin-like receptor genotypes on acute graft-vs-host disease after unrelated hematopoietic stem cell transplantation in Koreans.
Kim SY; Choi HB; Yoon HY; Choi EJ; Cho B; Kim HK; Kim YJ; Kim HJ; Min CK; Kim DW; Lee JW; Min WS; Kim CC; Kim TG
Tissue Antigens; 2007 Apr; 69 Suppl 1():114-7. PubMed ID: 17445182
[TBL] [Abstract][Full Text] [Related]
31. Killer immunoglobulin-like receptors.
Moretta L; Moretta A
Curr Opin Immunol; 2004 Oct; 16(5):626-33. PubMed ID: 15342010
[TBL] [Abstract][Full Text] [Related]
32. Human NK cells: From surface receptors to clinical applications.
Moretta L; Pietra G; Vacca P; Pende D; Moretta F; Bertaina A; Mingari MC; Locatelli F; Moretta A
Immunol Lett; 2016 Oct; 178():15-9. PubMed ID: 27185471
[TBL] [Abstract][Full Text] [Related]
33. NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation.
Ruggeri L; Mancusi A; Burchielli E; Capanni M; Carotti A; Aloisi T; Aversa F; Martelli MF; Velardi A
Blood Cells Mol Dis; 2008; 40(1):84-90. PubMed ID: 17964828
[TBL] [Abstract][Full Text] [Related]
34. Natural killer-cell KIR repertoire reconstitution after haploidentical SCT.
Stern M; de Angelis C; Urbani E; Mancusi A; Aversa F; Velardi A; Ruggeri L
Bone Marrow Transplant; 2010 Nov; 45(11):1607-10. PubMed ID: 20173785
[TBL] [Abstract][Full Text] [Related]
35. Alloreactive killer cells: hindrance and help for haematopoietic transplants.
Parham P; McQueen KL
Nat Rev Immunol; 2003 Feb; 3(2):108-22. PubMed ID: 12563295
[TBL] [Abstract][Full Text] [Related]
36. Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias.
Moretta A; Pende D; Locatelli F; Moretta L
Clin Exp Immunol; 2009 Sep; 157(3):325-31. PubMed ID: 19664139
[TBL] [Abstract][Full Text] [Related]
37. Natural killer cells in the treatment of high-risk acute leukaemia.
Locatelli F; Moretta F; Brescia L; Merli P
Semin Immunol; 2014 Apr; 26(2):173-9. PubMed ID: 24613727
[TBL] [Abstract][Full Text] [Related]
38. Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.
Giebel S; Nowak I; Dziaczkowska J; Czerw T; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Holowiecka-Goral A; Markiewicz M; Kopera M; Karolczyk A; Kyrcz-Krzemien S; Kusnierczyk P
Eur J Haematol; 2009 Oct; 83(4):343-56. PubMed ID: 19500138
[TBL] [Abstract][Full Text] [Related]
39. At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias.
Norell H; Moretta A; Silva-Santos B; Moretta L
J Leukoc Biol; 2013 Dec; 94(6):1123-39. PubMed ID: 24108703
[TBL] [Abstract][Full Text] [Related]
40. Killer cell Ig-like receptors ligand-mismatched, alloreactive natural killer cells lyse primary solid tumors.
Re F; Staudacher C; Zamai L; Vecchio V; Bregni M
Cancer; 2006 Aug; 107(3):640-8. PubMed ID: 16804934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]